Abstract:Tetrahedral framework nucleic acids carrying three miR‐124 (T‐miR3) are synthesized to explore their potential against osteoarthritis (OA). With reactive oxygen species scavenging ability and inflammation‐suppressive miR‐124 release behavior, T‐miR3 is observed to protect chondrocytes against IL‐1β injury in vitro and prevent OA progression by inhibiting chondrocyte apoptosis, smoothing cartilage surfaces, suppressing extracellular matrix degradation, and increasing synovial thickness, resulting in the protection of articular cartilage in vivo. MicroRNAs (miRNAs) regulate several physiological and pathological processes involved in various diseases, including osteoarthritis (OA). OA is the most common global musculoskeletal disorder, characterized by the irreversible progressive destruction of articular cartilage. Supplementation with exogenous miRNAs may represent a promising therapeutic OA treatment, with miRNA‐124 (miR‐124) being a prime candidate for its anti‐inflammatory ability; however, an effective drug delivery system is urgently required to enhance miR‐124 stability and capacity to enter chondrocytes. To this end, tetrahedral framework nucleic acids' (tFNAs) self‐assembled 3D DNA nanostructures possess superior inherent biocompatibility, versatile functionality, unsurpassed editability, and strong cellular internalization ability. In this study, tFNAs carrying one or three miR‐124 (T‐miR1 or T‐miR3) are successfully synthesized. T‐miR3 is largely absorbed via induced inflammatory chondrocytes by IL‐1β. With reactive oxygen species' scavenging ability and inflammation‐suppressive miR‐124 release behavior, T‐miR3 efficiently protects chondrocytes against IL‐1β injury in vitro. Additionally, T‐miR3 effectively prevents OA progression by inhibiting chondrocyte apoptosis, smoothing cartilage surfaces, suppressing extracellular matrix degradation, and increasing synovial thickness, effectively protecting in vivo articular cartilage, and illustrating the therapeutic ability of T‐miR3 in OA treatment. This study provides experimental evidence and novel therapeutic strategies for OA treatment in the clinical setting.

Tetrahedral Framework Nucleic Acid Loaded miR‐23b Inhibits Synovial Inflammation and Cartilage Matrix Degradation in the Treatment of Rheumatoid Arthritis

Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats

Amelioration of Osteoarthritis via Tetrahedral Framework Nucleic Acids Delivering Microrna‐124 for Cartilage Regeneration

MiR-23a Inhibited IL-17-mediated Proinflammatory Mediators Expression Via Targeting IKKα in Articular Chondrocytes.

Epigenetic regulatory axis MIR22‐TET3‐MTRNR2L2 represses fibroblast‐like synoviocyte‐mediated inflammation in Rheumatoid Arthritis

MiR-451 Inhibits Synovial Fibroblasts Proliferation and Inflammatory Cytokines Secretion in Rheumatoid Arthritis Through Mediating P38mapk Signaling Pathway.

Role of miRNAs in Rheumatoid Arthritis Therapy.

The Role of Interleukin-17 in Mediating Joint Destruction in Rheumatoid Arthritis

MiRNA-126 expression inhibits IL-23R mediated TNF-α or IFN-γ production in fibroblast-like synoviocytes in a mice model of collagen-induced rheumatoid arthritis

The Underlying Mechanism of Duanteng Yimu Decoction in Inhibiting Synovial Hyperplasia in Rheumatoid Arthritis

Curcumin relieved the rheumatoid arthritis progression via modulating the linc00052/miR-126-5p/PIAS2 axis

Inflammation‐Instructed Hierarchical Delivery of IL‐4/miR‐21 Orchestrates Osteoimmune Microenvironment toward the Treatment of Rheumatoid Arthritis

Effect of 1,25-(OH)2D3 on Proliferation of Fibroblast-Like Synoviocytes and Expressions of Pro-Inflammatory Cytokines Through Regulating MicroRNA-22 in a Rat Model of Rheumatoid Arthritis.

Targeting FGFR3 is a Useful Therapeutic Strategy for Rheumatoid Arthritis Treatment

MicroRNA‐17‐5p Reduces Inflammation and Bone Erosions in Mice With Collagen‐Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast‐like Synoviocytes

MicroRNA-143-3p ameliorates collagen-induced arthritis by polarizing naive CD4+ T cells into Treg cells.

Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients

MicroRNA-340-5p suppressed rheumatoid arthritis synovial fibroblast proliferation and induces apoptotic cell number by targeting signal transducers and activators of transcription 3

Anti-inflammatory Effects of Interleukin-23 Receptor Cytokine-Binding Homology Region Rebalance T Cell Distribution in Rodent Collagen-Induced Arthritis

Microrna-497 Reduction And Increase Of Its Family Member Microrna-424 Lead To Dysregulation Of Multiple Inflammation Related Genes In Synovial Fibroblasts With Rheumatoid Arthritis

The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis